Global Trauma Focus Target hospitals and regional distributors across 20+ countries to expand adoption of LOQTEQ and cannulated screws, with emphasis on trauma centers and orthopedic networks in Europe and beyond.

Innovation Pipeline Leverage upcoming antibacterial silver coating and magnesium-based implants as differentiators in tenders and partnerships, offering trials or pilot programs to showcase improved outcomes.

Mid Market Size Align sales efforts with the mid-sized company profile (50–200 employees) by offering flexible procurement, favorable payment terms, and bundled portfolio options to hospitals and purchasing groups.

Digital Readiness Highlight the integrated tech stack and data-driven capabilities to support hospitals’ digital procurement, inventory management, and training needs, positioning as a partner for modernization.

Strategic Partnerships Pursue collaborations with hospital groups and distributors in key regions to accelerate market penetration, supported by targeted marketing around LOQTEQ, biomaterials, and the antibacterial/biomaterial innovations.